Results 181 to 190 of about 38,241 (356)
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Faces of depression. Why do we need Batman, Joker, and Bane? [PDF]
Reghintovschi S, Reghintovschi AE.
europepmc +1 more source
Humanitarian inversions: COVID-19 as crisis. [PDF]
Herrick C, Kelly A, Soulard J.
europepmc +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié +13 more
wiley +1 more source
Paraphilia and Hypersexuality in Bipolar I Disorder and Histrionic Personality Disorder: A Case Report. [PDF]
Tavares TM +4 more
europepmc +1 more source
A Study of Oddity in a Russian Clinical Sample. [PDF]
Atadzhykova JA, Enikolopov SS.
europepmc +1 more source
Reticence or Theatrics? Grassroots Cadre Presence and Political Response in Survey
Jeffrey Dong Li
openalex +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source

